Development Level

Tchem 2 | 1,890
Tbio 1 | 10,625

IMPC Term

abnormal retina morphology 1 | 100
abnormal retinal pigmentation 1 | 61
abnormal startle reflex 1 | 14
decreased circulating fructosa... 1 | 31
decreased circulating sodium l... 1 | 18
decreased fasted circulating g... 1 | 49
increased bone mineral content 1 | 92
increased bone mineral density 1 | 52
increased circulating choleste... 1 | 53
preweaning lethality, incomple... 1 | 260

Disease

Cancer 3 | 2,346
glioblastoma 3 | 5,572
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
Alzheimer's disease 2 | 644
Arthritis 2 | 248
Brain disease 2 | 83
Breast cancer 2 | 3,094
Eye disease 2 | 55
Heart disease 2 | 279
Hyperglycemia 2 | 120
Kidney disease 2 | 396
Lung disease 2 | 132
Mammary Neoplasms 2 | 410
Neoplastic Cell Transformation 2 | 81
Obesity 2 | 616
Parkinson's disease 2 | 364
Reperfusion Injury 2 | 84
Stomach Neoplasms 2 | 282
Toxic encephalopathy 2 | 131
Vascular disease 2 | 281
acute myeloid leukemia 2 | 780
astrocytoma 2 | 1,493
diabetes mellitus 2 | 1,663
group 4 medulloblastoma 2 | 1,875
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
pilocytic astrocytoma 2 | 3,086
46 XY gonadal dysgenesis 1 | 9
46,XY SEX REVERSAL 6 1 | 1
Amyotrophic Lateral Sclerosis 1 | 431
Asthma 1 | 349
Brain Ischemia 1 | 87
Carcinoma 1 | 2,147
Colonic Neoplasms 1 | 126
Dermatitis, Atopic 1 | 45
Fatty liver disease 1 | 84
Gastrointestinal system disease 1 | 50
Gonadal dysgenesis 1 | 6
Heat Stroke 1 | 12
Hemangiosarcoma 1 | 18
Intestinal Polyps 1 | 5
Juvenile arthritis 1 | 124
Liver Failure, Acute 1 | 22
Liver carcinoma 1 | 217
Liver disease 1 | 219
Liver neoplasms 1 | 109
Lung Neoplasms 1 | 171
Malignant neoplasm of breast 1 | 63
Mercury Poisoning, Nervous System 1 | 1
Metabolic syndrome X 1 | 155
Osteoporosis 1 | 257
Peripheral Neuropathy 1 | 303
Precancerous Conditions 1 | 69
Rheumatoid Arthritis 1 | 1,160
Status Epilepticus 1 | 85
Swyer Syndrome 1 | 8
Type 2 diabetes mellitus 1 | 189
Waldenstrons macroglobulinemia 1 | 765
acute quadriplegic myopathy 1 | 1,157
adult high grade glioma 1 | 2,148
aldosterone-producing adenoma 1 | 664
atypical teratoid / rhabdoid tumor 1 | 4,369
atypical teratoid/rhabdoid tumor 1 | 1,095
breast carcinoma 1 | 1,614
chronic lymphosyte leukemia 1 | 232
colon cancer 1 | 1,475
cystic fibrosis 1 | 1,665
fibroadenoma 1 | 557
gastric cancer 1 | 430
hepatocellular carcinoma 1 | 532
inflammatory breast cancer 1 | 404
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
juvenile dermatomyositis 1 | 1,189
nephrosclerosis 1 | 329
non-small cell lung cancer 1 | 2,798
pancreatic cancer 1 | 2,300
pancreatic carcinoma 1 | 567
pediatric high grade glioma 1 | 2,712
pituitary cancer 1 | 1,972
posterior fossa group B ependymoma 1 | 1,530
primitive neuroectodermal tumor 1 | 3,031
psoriasis 1 | 6,685
pterygium 1 | 74
sonic hedgehog group medulloblastoma 1 | 1,482
spina bifida 1 | 1,064
tuberculosis 1 | 1,557
tuberculosis and treatment for 3 months 1 | 327
tuberculosis and treatment for 6 months 1 | 686

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Kinase 2 | 634
Transcription Factor 1 | 1,400

Grant Application

3R01EY015227-06S1 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Mitogen-activated protein kinase 8 MAPK8 Tchem Kinase -3.75582 5333.9 1016
Transcription factor AP-1 JUN Tchem Transcription Factor -3.80760 5981.8 2262
Mitogen-activated protein kinase kinase kinase 1 MAP3K1 Tbio Kinase -2.07309 110.8 261